Trial Details

Not Recruiting
Basic Information
Clinical ID c3220
Identifier EUCTR2010-023947-14-ES
Trial Title Prospective, Randomized and Comparative Study to evaluate the efficacy of two vaccines against Hepatitis B virus in inflammatory bowel disease patients - COMVI-B Proyect
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Prophylaxis against Hepatitis B virus MedDRA version: 14.0_Level: LLT_Classification code 10019743_Term: Hepatitis B virus (HBV)_System Organ Class: 10022891 - Investigations_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Trade Name: ENGERIX-B 20mg / 1ml suspensn inyectable en jeringa precargada Product Name: FENDRIX Product Code: Not Applicable Pharmaceutical Form: Solution for injection INN or Proposed INN: ANTIGENO SUPERFICIE HEPATITIS B Other descriptive name: ANTIGENO SUPERFICIE HEPATITIS B Concentration unit: mg microgram(s) Concentration type: equal Concentration number: 40- Trade Name: FENDRIX, suspensin inyectable Pharmaceutical Form: Solution for injection INN or Proposed INN: ANTIGENO SUPERFICIE HEPATITIS B Other descriptive name: ANTIGENO SUPERFICIE HEPATITIS B Concentration unit: mg microgram(s) Concentration type: equal Concentration number: 20-
Participant Information
Sponsor Hospital Universitario La Princesa
City -
Country/Region Spain
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE3
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -